University of British Columbia | HPV vaccine offers lasting protection for women living with HIV, study finds
A long-term study published in The Lancet HIV confirms that the HPV vaccine provides lasting protection for women living with HIV. This finding is critical for global efforts to eliminate cervical cancer, as this population faces significantly higher risks.
Why it matters
This research provides essential medical evidence to improve health outcomes for a vulnerable population and supports global public health goals.
The HPV vaccine provides strong, long-lasting protection for women living with HIV, study finds.
The findings provide important new evidence as countries work toward the World Health Organization’s goal of eliminating cervical cancer . Women living with HIV are six times more likely to be infected with HPV and twice as likely to die from invasive cervical cancer than those without HIV, making vaccination particularly important for this population.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in